Concepedia

Blood–brain barrier disruption is associated with increased mortality after endovascular therapy

Jean‐Philippe Désilles, Aymeric Rouchaud, Julien Labreuche, Elena Meseguer, Jean‐Pierre Laissy, Jean‐Michel Serfaty, Bertrand Lapergue, Isabelle Klein, Céline Guidoux, Lucie Cabrejo,

Neurology · 2013 · 119 citations · 29 references

DOI

Abstract

BBB disruption has a detrimental effect on outcome and is independently associated with mortality after endovascular therapy. BBB disruption assessment may have a role in prognosis staging in these patients.

References

29

Tissue Plasminogen Activator for Acute Ischemic Stroke

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group · New England Journal of Medicine · 1995 · 11.6K citations

, , +17

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

Werner Hacke, Markku Kaste, Erich Bluhmki et al. · New England Journal of Medicine · 2008 · 6.5K citations · Full text

The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings

Hiltrud S. Mueller, A. R. DYER, Mark A. Greenberg · 1985 · 3.6K citations

, , +7

The Thrombolysis in Myocardial Infarction (TIMI) Trial

New England Journal of Medicine · 1985 · 3.2K citations

, , +10

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy

Philip A. Barber, Andrew M. Demchuk, Jinjin Zhang et al. · The Lancet · 2000 · 2.6K citations

, , +17